Form 4: Perceptive Advisors Reports LONA Stock Option Grant

Perceptive Advisors LLC, along with related entities and Joseph Edelman, reported the acquisition of stock options for LeonaBio, Inc. (LONA) on April 9, 2026.

Summary

• Perceptive Advisors LLC, Perceptive Life Sciences Master Fund Ltd., and Joseph Edelman have reported transactions related to LeonaBio, Inc. (LONA).
• The primary transaction involves a stock option grant to acquire 28,000 shares of common stock at an exercise price of $9.54 per share, with an expiration date of April 8, 2036.
• These options are subject to vesting over 24 months from the grant date, contingent on continued service as a Service Provider.
• Joseph Edelman, as managing member of Perceptive Advisors LLC and through its role as investment manager for Perceptive Life Sciences Master Fund Ltd., has indirect beneficial ownership and pecuniary interest in these securities.
• The reporting persons are identified as Directors and 10% Owners of LeonaBio, Inc.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it reports a standard stock option grant to insiders, which is a common compensation and incentive tool rather than an indicator of immediate positive or negative company performance.

Positives

• Grant of stock options indicates potential for future value appreciation for the reporting persons.
• The reporting persons are significant stakeholders, holding director and 10% owner positions, suggesting alignment with company performance.
• The option grant provides an incentive for continued service and contribution to the company's success.

Negatives

• The filing does not contain any negative financial results or operational setbacks.

Risks

• The value of the stock options is contingent on the future performance of LeonaBio, Inc. and the market price of its common stock.
• Vesting of the options is dependent on continued service, introducing employment risk for the option holder.
• The exercise price of $9.54 per share means the options will only be profitable if the stock price exceeds this level.

Future Outlook

The future outlook is tied to the vesting and potential exercise of the granted stock options, which is dependent on the company's performance and the continued service of the optionee.

Management Comments

• Joseph Edelman, on behalf of Perceptive Advisors LLC and Perceptive Life Sciences Master Fund Ltd., disclaims beneficial ownership except to the extent of indirect pecuniary interest, and this report shall not be deemed an admission of beneficial ownership for Section 16 or any other purpose.

Industry Context

StockSavvy.ai notes that Form 4 filings are standard for reporting insider transactions, including option grants, which are common in the biotechnology sector to incentivize key personnel and align interests with shareholders.

Related Party Transactions

• The filing details a stock option grant to individuals and entities associated with Perceptive Advisors LLC, which includes Joseph Edelman, who is a director and 10% owner.

Stakeholder Impact

• Shareholders: The option grant could lead to future dilution if exercised, but also aligns management incentives with shareholder value creation.
• Employees: The vesting schedule incentivizes continued employment and performance.
• Management: Joseph Edelman and associated entities benefit from potential future gains on the stock options.

Next Steps

• The stock options will vest monthly over 24 months.
• The reporting persons will continue to hold their director and 10% owner positions.
• The value of the options will be realized if the stock price exceeds the exercise price of $9.54 by the expiration date of April 8, 2036.

Key Dates

Keywords

Form 4, SEC Filing, Stock Options, LeonaBio, LONA, Perceptive Advisors, Joseph Edelman, Beneficial Ownership, Insider Trading, Equity Incentive Plan